POM Investment Strategies’s Medtronic MDT Stock Holding History

POM Investment Strategies’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.65K	Sell	19 -30	-61%	-$2.87K	﹤0.01%	381
2025 Q4	$4.71K	Buy	+49	New	+$4.76K	﹤0.01%	207
2025 Q2	–	Sell	-33	Closed	-$2.96K	–	194
2025 Q1	$2.96K	Sell	33 -60	-65%	-$5.37K	﹤0.01%	134
2024 Q4	$7.43K	Buy	93 +30	+48%	+$2.6K	0.01%	195
2024 Q3	$5.67K	Buy	63 +2	+3%	+$168	﹤0.01%	169
2024 Q2	$4.8K	Buy	61 +28	+85%	+$2.29K	﹤0.01%	224
2024 Q1	$2.88K	Hold	33	–	–	﹤0.01%	166
2023 Q4	$2.72K	Buy	+33	New	+$2.52K	﹤0.01%	158

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

POM Investment Strategies's MDT Position: Q1 2026 in Review

POM Investment Strategies reduced its Medtronic (MDT) stake by 61% in Q1 2026, selling an estimated $2.87K and leaving 19 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #381.

POM Investment Strategies first reported a position in MDT in Q4 2023 and has held it in 8 quarters since. The position peaked at $7.43K in Q4 2024. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

POM Investment Strategies held 19 shares of Medtronic worth $1.65K as of Q1 2026.
POM Investment Strategies sold 30 Medtronic shares in Q1 2026, an estimated $2.87K.
Medtronic made up ﹤0.01% of POM Investment Strategies's portfolio in Q1 2026, its #381 holding.
POM Investment Strategies first reported a position in Medtronic in Q4 2023 and has held it in 8 quarters since.
POM Investment Strategies's Medtronic position peaked at $7.43K in Q4 2024.
2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on POM Investment Strategies's 13F filing for Q1 2026, filed 11 May 2026.